| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 152657-84-6 | Nalfurafine | C28H32N2O5 |
| 152658-17-8 | Nalfurafine hydrochloride | C28H32N2O5.HCl |
| 152670-41-2 | N,N'-Di(1-naphthyl)-4,4'-benzidine | C32H24N2 |
| 152684-26-9 | 5-Bromo-3-methoxy-2-nitro-pyridine | C6H5BrN2O3 |
| 152684-30-5 | 5-Bromo-2-methoxy-3-nitropyridine | C6H5BrN2O3 |
| 152685-91-1 | Cimiside B | C40H64O13 |
| 152697-45-5 | Uridine 5'-diphosphoglucose | C15H24N2O17P2 |
| 152708-24-2 | Valsartan azide impurity | C14H11N7 |
| 152743-19-6 | Lysionotin | C18H16O7 |
| 152751-57-0 | Sevelamer hydrochloride | (C3H7N)m.(C3H5ClO)n.(HCl)x |
| 152763-53-6 | Thulium tris[bis(trimethylsilyl)amide] | 3(C6H18NSi2).Tm |
| 152772-65-1 | L-Gluconic acid calcium salt (2:1) | 2(C6H11O7).Ca |
| 152775-45-6 | 3,5-Dimethyl-4-methoxybenzonitrile | C10H11NO |
| 152784-32-2 | 4-(2,4-Dihydroxyphenyl)-5-[(4-hydroxyphenyl)methyl]-2(5H)-furanone | C17H14O5 |
| 152787-59-2 | Proteinase inhibitor, TCPI | |
| 152803-24-2 | 5-Hydroxynicotinonitrile | C6H4N2O |
| 152807-26-6 | 3-(4'-Fluorobenzoyl)indole | C15H10FNO |
| 152811-62-6 | Piboserod | C22H31N3O2 |
| 152812-42-5 | Methyl 2-chloroindole-3-carboxylate | C10H8ClNO2 |
| 152828-23-4 | N-[5-(1,1-Dimethylethyl)-1H-pyrazol-3-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide | C14H17N5O3 |
| 152828-25-6 | 2-(4-Aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole | C12H11N5 |
| 152840-65-8 | 2,6-Dichloro-5-fluoro-3-pyridinamine | C5H3Cl2FN2 |
| 152840-71-6 | 1-Bromo-3-chloro-2,4,5-trifluorobenzene | C6HBrClF3 |
| 152854-19-8 | 3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methyl-pyridine (2R,3R)-2,3-dihydroxybutanedioate (1:1) | C14H23N3OS .C4H6O6 |
| 152894-10-5 | N,N-Bis(pentafluoroethanesulphonyl)imide | C4HF10NO4S2 |
| 152897-19-3 | 1,1,3,3-Tetramethoxycyclobutane | C8H16O4 |
| 152914-68-6 | Undecyl 2-acetamido-2-deoxy-beta-D-glucopyranoside | C19H37NO6 |
| 152918-18-8 | N6-(3-Iodobenzyl)adenosine-5'-N-methyluronamide | C18H19IN6O4 |
| 152918-47-3 | 1-(6-Chloro-9H-purin-9-yl)-1-deoxy-N-methyl-2,3-O-isopropylidene-beta-D-ribofuranuronamide | C14H16ClN5O4 |
| 152922-71-9 | 1-(Hydroxymethyl)cyclopropaneacetonitrile | C6H9NO |
| 152922-73-1 | Methyl 1-(Mercaptomethyl)cyclopropaneacetate | C7H12O2S |
| 152923-56-3 | Daclizumab | |
| 152923-57-4 | Lutropin | |
| 152932-65-5 | O-6-Deoxy-alpha-L-galactopyranosyl-(1$rarr$3)-O-[3-O-sulfo-beta-D-galactopyranosyl-(1$rarr$4)]-2-(acetylamino)-2-deoxy-beta-D-glucopyranose | C20H35NO18S |
| 152937-04-7 | 2-Bromo-6-fluorobenzothiazole | C7H3BrFNS |
| 152940-76-6 | 1-[(4-Bromophenyl)sulfonyl]-1H-imidazole | C9H7BrN2O2S |
| 152943-33-4 | Bupropion USP Related Compound C | C9H9ClO2 |
| 152946-68-4 | Nolatrexed dihydrochloride | C14H12N4OS.2(HCl) |
| 152957-34-1 | 2-Nitrophenyl 2-(acetylamino)-2-deoxy-beta-D-galactopyranoside | C14H18N2O8 |
| 152983-87-4 | [5S(2S,4R)]-5-C-(4-Carboxy-2-thiazolidinyl)-1-deoxy-L-arabinitol | C9H17NO6S |
| 153004-31-0 | (7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol | C32H47F5O2S |
| 153012-08-9 | 2-Deoxy-2,2-difluoro-D-ribofuranose-3,5-dibenzoate | C19H16F2O6 |
| 153012-37-4 | Precursor of cefcapene diisopropylanmine salt | C22H27N5O8S2.C6H15N |
| 153028-00-3 | 2-Ethynyl-4-thiazolemethanol | C6H5NOS |
| 153034-78-7 | 2-Fluoro-3-iodo-5-methylpyridine | C6H5FIN |
| 153034-80-1 | 2-Fluoro-4-iodo-3-methylpyridine | C6H5FIN |
| 153034-82-3 | 2-Fluoro-4-iodopyridine-3-carboxaldehyde | C6H3FINO |
| 153034-83-4 | 2-Fluoro-3,4-diiodopyridine | C5H2FI2N |
| 153034-86-7 | 2-Chloro-4-iodopyridine | C5H3ClIN |
| 153034-88-9 | 2-Chloro-4-iodo-3-methylpyridine | C6H5ClIN |